trending Market Intelligence /marketintelligence/en/news-insights/trending/jtSwxh_ErKwhuNYKsEKeKw2 content esgSubNav
In This List

Trice Medical concludes $19.3M series C financing round

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Trice Medical concludes $19.3M series C financing round

Trice Medical Inc. closed a series C financing round, raising $19.3 million.

The company will use proceeds to accelerate and expand the company's U.S. market penetration for its mi-eye 2 technology.

The mi-eye 2 is a disposable needle with a wide-angle camera that allows physicians to diagnose joint injuries from the doctor's office.

Trice Medical has raised $40.9 million to date, including the series C financing round, which saw Smith & Nephew PLC take a minority stake in the company.